Viewing StudyNCT05917561



Ignite Creation Date: 2024-05-06 @ 7:10 PM
Last Modification Date: 2024-10-26 @ 3:01 PM
Study NCT ID: NCT05917561
Status: RECRUITING
Last Update Posted: 2023-12-22
First Post: 2023-05-31

Brief Title: Efficacy and Tolerance of the Association of ANIFROLUMAB 300mg IV Every Four Weeks and Phototherapy Versus Phototherapy in Adults With Progressive Vitiligo
Sponsor: University Hospital Bordeaux
Organization: University Hospital Bordeaux

Conditions & Keywords Data

Conditions:
Name
Vitiligo
Keywords:
Name View
randomized View
anifrolumab View
vitiligo View
phototherapy View